Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels

Lewis, 1993, The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004 Ravid, 1993, Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria innormotensive type II diabetic patients, Ann Intern Med, 118, 577, 10.7326/0003-4819-118-8-199304150-00001 Maschio, 1996, Effect of angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group, N Engl J Med, 334, 939, 10.1056/NEJM199604113341502 Ruggenenti, 1998, Renal function and requirement for dialysis in chronic nephropathy patients on long term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN): Ramipril Efficacy in Nephropathy, Lancet, 352, 1252, 10.1016/S0140-6736(98)04433-X Andersen, 2000, Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy, Kidney Int, 57, 601, 10.1046/j.1523-1755.2000.00880.x Ogihara, 1981, Hormonal responses to long term converting enzyme inhibition in hypertensive patients, Clin Pharmacol Ther, 30, 328, 10.1038/clpt.1981.168 Brunner, 1983, Long term clinical experience with enalapril in essential hypertension, J Hypertens, 1, 103 Messerli, 1996, Angiotensin II receptor inhibition: A new therapeutic principle, Arch Intern Med, 156, 1957, 10.1001/archinte.1996.00440160069010 Weber, 1999, Interrupting the renin angiotensin system: The role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension, Am J Hypertens, 12, 189S, 10.1016/S0895-7061(99)00105-3 Russo, 1999, Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy, Am J Kidney Dis, 33, 851, 10.1016/S0272-6386(99)70416-6 Ruilope, 2000, Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease, J Hypertens, 18, 89, 10.1097/00004872-200018010-00013 De Nicola, 1993, Arginine feeding modifies cyclosporine nephrotoxicity in rats, J Clin Invest, 92, 1859, 10.1172/JCI116777 Garcia, 1996, Effect of angiotensin II on renal response to amino acid in rats, Am J Kidney Dis, 28, 115, 10.1016/S0272-6386(96)90139-0 Garcia, 1997, Effect of reduction of nitric oxide on plasma and kidney tissue angiotensin II levels, Am J Hypertens, 10, 1103, 10.1016/S0895-7061(97)00123-4 Taal, 2000, Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists, Kindey Int, 57, 1803, 10.1046/j.1523-1755.2000.00031.x Kang, 1994, Angiotensin II receptor antagonists: A new approach to blockade of the renin angiotensin system, Am Heart J, 127, 1388, 10.1016/0002-8703(94)90061-2 Eberhardt, 1993, Angiotensin II receptor blockade: An innovative approach to cardiovascular pharmacotherapy, J Clin Pharmacol, 33, 1023, 10.1002/j.1552-4604.1993.tb01939.x Fox, 1992, Dietary sodium and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats, Am J Physiol, 262, F902 Lafayette, 1992, Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass, J Clin Invest, 90, 766, 10.1172/JCI115949 Pollock, 1993, Angiotensin II receptor blockade improves renal function in rats with reduced renal mass, J Pharmacol Exp Ther, 267, 657 Remuzzi, 1993, Short- and long term effect of angiotensin II receptor blockade in rats with experimental diabetes, J Am Soc Nephrol, 4, 40, 10.1681/ASN.V4140 Amuchastegui, 1998, Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism, J Am Soc Nephrol, 9, 1948, 10.1681/ASN.V9101948 Zou, 1996, Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats, Hypertension, 28, 669, 10.1161/01.HYP.28.4.669 Hunley, 2000, The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 nullmutant mice, Kidney Int, 57, 570, 10.1046/j.1523-1755.2000.00877.x Zou, 1996, Renal accumulation of circulating angiotensin II in angiotensin II-infused rats, Hypertension, 27, 658, 10.1161/01.HYP.27.3.658 Wilkinson-Berka, 2001, Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic(mRen-2)27 rat, Nephrol Dial Transplant, 16, 1343, 10.1093/ndt/16.7.1343 Mombouli, 1992, Heterogeneity of endothelium dependent vasodilator effects of angiotensin -converting enzyme inhibitors: Role of bradykinin generation during ACE inhibition, J Cardiovasc Pharmacol, 20, S74, 10.1097/00005344-199200209-00014 Kon, 1993, Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition, Kidney Int, 44, 545, 10.1038/ki.1993.279 Fahry, 1993, Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation, Circ Res, 72, 1202, 10.1161/01.RES.72.6.1202 Ran, 1999, Renal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice, J Am Soc Nephrol, 10, 2620, 10.1681/ASN.V10122620 Handa, 1999, Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands, J Pharmacol Exp Ther, 291, 1242 Loufrani, 1999, Functional evidence for an angiotensin IV receptor in rat resistance arteries, J Pharmacol Exp Ther, 291, 583 Fitzgerald, 1999, Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats, J Cardiovasc Pharmacol, 34, 206, 10.1097/00005344-199908000-00005